A Phase II Study of Secondary Cytoreduction with and without HIPEC plus Postoperative Chemotherapy for Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Cytoreduction and Heated Intraperitoneal Chemotherapy (HIPEC)
Leonard Henry, M.D.
Indiana University Health, Goshen Hospital, Goshen, IN
Click here to schedule a phone conversation with Dr. Henry
Regional Therapeutics for Advanced Malignancies is a concise guide to treatment of cancer in different parts of the body. Divided into four sections, this book covers peritoneal disease; gynaecological malignancies; melanoma, sarcoma and lung; and liver. Each section discusses different treatments that may be used to treat cancer within that part of the body. Authored by recognised specialists in the UK and USA, this manual contains more than 120 colour images and illustrations. Key Features * Concise guide to treatment of cancer in different regions of the body * Covers peritoneal disease, gynaecological malignancies, melanoma, sarcoma and lung; and liver * Each section discusses different treatment options for that region * Recognised authors from UK and USA * More than 120 colour images and illustrations.
This book investigates intraperitoneal chemotherapy in a variety of complex and interesting ways. The volume details major clinical trails to date. Authors also examine regional approaches to therapy, systemic therapy, and the use of carboplatin and paclitaxel as the standard treatment for women with stages III and IV ovarian cancer. The future direction of intraperitoneal chemotherapy both normothermic and hyperthermic is also covered.
This issue of the "Surgical Oncology Clinics of North America, Guest" Edited by Dr. Jesus Esquivel, will focus on the current status and future directions of the treatment of the most common peritoneal surface malignancies: appendix cancer, colorectal cancer, ovarian cancer, gastric cancer, and peritoneal mesothelioma. This issue will also outline some of the most common issues that arise regarding cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC), such as pharmacokinetic rationale of heat and intraperitoneal chemotherapy, HIPEC techniques and safety considerations, how to start a peritoneal surface malignancy program, anesthesia considerations during cytoreductive surgery and HIPEC, patient selection for cytoreductive surgery and HIPEC, and the role of systemic chemotherapy in the management of peritoneal surface malignancies of appendiceal and colorectal origin.